.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Johnson and Johnson
Cantor Fitzgerald
Novartis
McKesson
AstraZeneca
Farmers Insurance
Cipla
McKinsey

Generated: January 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9904934.8

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-002Mar 30, 2009RXYesYes➤ Subscribe➤ SubscribeY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-001Aug 29, 2012RXYesNo➤ Subscribe➤ SubscribeY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-002Aug 29, 2012RXYesNo➤ Subscribe➤ SubscribeY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-003Aug 29, 2012RXYesYes➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo➤ Subscribe➤ SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist